checkAd

CureVac CTO Fotin-Mleczek Resigns

(PLX AI) – CureVac says Chief Technology Officer Mariola Fotin-Mleczek will resign from CureVac effective January 31, 2022. Mariola was responsible for the development and preclinical testing of CureVac's mRNA technology platform across the …

  • (PLX AI) – CureVac says Chief Technology Officer Mariola Fotin-Mleczek will resign from CureVac effective January 31, 2022.
  • Mariola was responsible for the development and preclinical testing of CureVac's mRNA technology platform across the therapeutic areas of prophylactic vaccines, oncology and molecular therapy
  • Further development of CureVac's unique mRNA technology platform will be led by Dr. Igor Splawski, Chief Scientific Officer of CureVac, and spearheaded by Dr. Patrick Baumhof, Senior Vice President Technology, who has a 15-year scientific tenure with the company

So handeln Sie das Kursziel

Der Analyst erwartet ein Kursziel von 18,65$, was einem Rückgang von +-0,44% zum aktuellen Kurs entspricht. Mit diesen Produkten können Sie die Kurserwartungen des Analysten übertreffen.
Übernehmen
Für Ihre Einstellungen haben wir keine weiteren passenden Produkte gefunden.
Bitte verändern Sie Kursziel, Zeitraum oder Emittent.Alternativ können Sie auch unsere Derivate-Suchen verwenden
Knock-Out-Suche | Optionsschein-Suche | Zertifikate-Suche
WerbungDisclaimer
Wertpapier


0 Kommentare
Autor: PLX AI
 |  193   |  0   |   

Schreibe Deinen Kommentar

Disclaimer

CureVac CTO Fotin-Mleczek Resigns (PLX AI) – CureVac says Chief Technology Officer Mariola Fotin-Mleczek will resign from CureVac effective January 31, 2022. Mariola was responsible for the development and preclinical testing of CureVac's mRNA technology platform across the …

Nachrichten des Autors

Titel
Bavarian Nordic Surges Another 22% as Monkeypox Vaccine Could Be Game Changer, Danske Says
Siemens Sells Commercial Vehicles Business to Meritor for Enterprise Value EUR 190 Million
Ross Stores FY Outlook Below Consensus; Shares Collapse After Market
Ambu Names Britt Meelby Jensen New CEO Following Departure of Gonzalez; Guidance Unchanged
Cisco Q3 Earnings Miss Expectations; Q4 Guidance Well Below Consensus
Daimler Truck Q1 Earnings Beat Expectations; EBIT Guidance Raised
Take-Two Q4 Earnings Beat Expectations; Gives New Guidance
Vestas Introducing 4.5 MW Wind Turbine for Medium to Low Wind Conditions
Ørsted Buys Onshore Wind Farm in USA
Dermapharm Q1 Adjusted EBITDA EUR 75.1 Million
Titel
Telefonica Subsidiary Telefonica Tech Buys BE-terna Group for up to EUR 350 Million
Plug Power Q1 Revenue Below Expectations; Keeps FY Targets Unchanged
TeamViewer Q1 Adjusted EBITDA EUR 83.2 Million vs. Estimate EUR 62 Million
Nel Q1 Revenue NOK 213 Million vs. Estimate NOK 248 Million
Tomra Systems Q1 EBITA NOK 237 Million vs. Estimate NOK 248 Million
Vonovia Q1 Net Income EUR -29.1 Million
Sixt Hit by Cyber Attack, Says Impact Was Minimized
AbbVie Q1 Adj. EPS Tops Estimates; Guidance Cut on Milestone Expense
Block Q1 Revenue Misses Estimates, but Adj. EBITDA Is Ahead
Evotec Q1 Adjusted EBITDA EUR 18.9 Million
Titel
Nokia Reinstated with Neutral Rating at Bank of America
Stillfront buys Jawaker for USD 205 Million in Cash and Shares; to Issue New Shares for SEK 1 ...
Dentsply Sirona Fired CEO Casey; Board Member Groetelaars Takes Over Temporarily
Viatris Sells Biosimilars Portfolio to Biocon Biologics for up to $3.335 Bilion
Novo Nordisk Rises as Wegovy Demand Leads to Shortage in U.S.
Rexel Buys Mayer for Enterprise Value $456 Million
Biomerieux Buys Specific Diagnostics for Price Equivalent to 3.3% of Market Cap
Nordex Rises as Bank of America Sees Strong Orders in Q3
Plug Power Q4 Revenue Beats Expectations; Sees Fuel Margins Breakeven by 2023
Amazon Jumps 7% After Earnings; Takes $11.8 Billion Gain from Rivian